• Rejuvenate Bio

  Participated · Equity · Jun 2026

  Rejuvenate Bio develops gene therapies aimed at extending healthy lifespan and treating chronic, age-associated diseases by combining advances in gene delivery, translational biology, and longevity science. The company has built a pipeline targeting clinically validated gene targets with a delivery approach designed for well-tolerated, durable expression. Rejuvenate Bio is developing therapies for companion animals with the stated goal of translating insights toward human health applications. The company was founded on research from the Wyss Institute at Harvard Medical School and is headquartered in San Diego, CA. Following the announced $6 million financing, Rejuvenate Bio has also entered a strategic R&D collaboration with Merck Animal Health to advance a targeted animal-health gene therapy program.

• Faeth Therapeutics

  Participated · Series A · Jun 2022

  Faeth Therapeutics, headquartered in Austin, Texas, is advancing multi-node therapies that block cancer growth signals while controlling tumor fuel supply. Its proprietary, AI-driven MetabOS platform uncovers metabolic dependencies in tumors and other diseases, guiding the development of therapeutic and nutritional interventions. The company’s lead program is a Phase 2 study in endometrial cancer that is expected to deliver a full data readout in Q3 2026. Additional plans include a Phase 1 trial in locally advanced rectal cancer using a non-essential amino acid-restricted regimen and an investigational program for Hereditary Tyrosinemia Type 1, the first application of MetabOS beyond oncology. Founded in 2019 by noted scientists Lewis Cantley, Siddhartha Mukherjee, Karen Vousden, Scott Lowe, and Greg Hannon, the company is led by CEO Anand Parikh. To date, Faeth has raised $92 million in capital to fund its pipeline and expand the MetabOS platform.

• Ness

  Participated · Seed · May 2022

  Ness builds credit cards and the Ness Rewards App to help consumers earn points for health-related spending and activities and redeem them at wellness brands like Sweetgreen, Thrive Market, and Barry’s Bootcamp. The company intends to expand rewards to cover all “healthy actions,” from fitness activity to physician visits. Ness is launching a suite of credit cards to accelerate rewards and provide cardholders exclusive benefits from health and wellness brands. The company plans to layer medical benefits, supplemental insurance, and comprehensive health insurance on top of its cards. Ness also announced the acquisition of WellSet’s 4,000-person nationwide network of practitioners. It raised seed funding to grow the product, team, userbase, and its commitment to credit and compliance.

• Kingdom Supercultures

  Participated · Series A · Oct 2021

  Kingdom Supercultures designs and supplies a new class of natural ingredients called Supercultures, composed entirely of microbial strains found naturally in food that are rearranged into new combinations with new functionalities. Manufacturers use these Supercultures to create plant-based yogurts and cheeses, lower-alcohol wines and beers with full flavor, and personal care products without artificial chemicals. The company says its products aim to transform the consumer packaged goods industry by making it easier to create healthy and sustainable products. Kingdom plans to use the funds from its recent Series A to expand its scientific platform and R&D facilities. The company is led by CEO Kendall Dabaghi and is based in New York. It raised $25M in the Series A announced in May 2021.

• Ansel Health

  Participated · Equity · Aug 2020

  Ansel provides a modern supplemental health insurance product that issues cash payouts upon diagnosis for more than 13,000 conditions, with no accident or hospitalization requirements. The company emphasizes a simplified, paperless enrollment and claims experience and has implemented claims automation that leverages medical claims data so members can receive benefits without filing claims. Ansel partners with established insurance carriers and benefits brokerages to distribute its plans and reported a net promoter score of 90 in 2023. The product is available in partnership with carriers across 39 states and the company is working toward nationwide availability. Founded in 2019, Ansel rebranded and adopted its current name and visual identity entering 2024. The company has raised over $50M to date and is using the new capital to expand availability of its supplemental insurance solution nationwide. Brella Insurance offers a tech-enabled supplemental health insurance plan that pays cash on diagnosis for more than 13,000 conditions. The product is designed for distribution through employers, brokers, and strategic partners and emphasizes simple implementation and administration. Brella positions its plan as broader than traditional supplemental products, which the company says are too narrow and have outdated claims and administration processes. The company is actively engaging brokers and employers in Texas and planned launches in additional states in Q2 2021 to support nationwide expansion. Brella says the financing will fund its national expansion and alliances with leading benefits brokerage firms and strategic partners. Since inception the company has raised over $22M in total funding. Brella Insurance provides a supplemental health insurance plan designed for Texas-based employers and their teams. The plan pays cash upon diagnosis of any of more than 13,000 covered conditions, including many complications associated with COVID-19, to complement traditional health insurance. Founded in 2019 by Veer Gidwaney (formerly CEO and co‑founder of Maxwell Health) and previously known as Clara Insurance, the company is focused on employer benefits. Brella has partnered with RGAx and Greenhouse Life Insurance Company, subsidiaries of Reinsurance Group of America, to bring its solution to the employee benefits market. Financially, the company has raised over $7M in total funding after an additional $1.5M round. Brella is actively engaging brokers and employers in Texas to grow adoption.

No current team members are available.